Hamilton, Bermuda

Kamal K Midha

This inventor holds 12 USPTO granted patents. Top assignees: Pharmaquest Limited, Collegium Pharmaceutical, Inc., Peirce Management, LLC. Active years: 2000-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kamal K Midha. Retrieved from https://idiyas.com/inventor/kamal-k-midha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 2.6

ph-index = 10

Forward Citations = 423(Granted Patents)


Location History:

  • Hamilton HM, BM (2003)
  • Hamilton, BM (2000 - 2008)

Company Filing History:


Years Active: 2000-2008

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Kamal K Midha - Pioneering Innovations in Hamilton

Introduction: Kamal K Midha is a distinguished inventor based in Hamilton, Bermuda, known for his groundbreaking contributions to various technological fields.

Latest Patents: Kamal K Midha holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Kamal K Midha has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Kamal K Midha has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Kamal K Midha's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…